Total
0
Shares
HeraMED adds telehealth services to Herabeat in Germany
  • Medical technology company HeraMED will partner with German midwife service provider, Kinderheldin, to add a telehealth service to its portfolio
  • The company's HeraBEAT device allows expecting mothers to monitor their baby's heart beat using an ultrasonic monitor
  • The agreement will see the release of HeraBEAT plus, that will provide online midwife support to mothers using the device
  • Existing partner Duttenhofer will also be involved in the two-year agreement
  • Shares are down 4.08 per cent and trading for 23.5 cents each

Medical technology company HeraMED will partner with midwife service provider Kinderheldin to launch a telehealth service.

Kinderheldin, a German company, already has an online platform where expecting parents can talk to midwives.

The new partnership will see HeraMED's foetal heartbeat monitor, HeraBEAT, connected to Kenderheldin's online midwife service. The telehealth feature will be incorporated into a new device, the HeraBEAT Plus and launched in Germany.

Kinderheldin's midwives will be able to access the heartbeat information via the platform to provide more informed and immediate advice.

Initially, the telehealth feature will be complimentary and then be operated as a subscription service.

In addition to the two-year agreement with Kinderheldin, HeraMED has tabled plans for the two companies to commence discussion regarding the product with both healthcare providers and insurance companies in Germany. Kinderheldin is well connected with over 50 insurance company partnerships and 5 major hospital partnerships.

Existing partner Duttenhofer Group will also be part of the HearBEAT Plus collaboration. In August this year, HeraMED announced an agreement with Duttenhofer to distribute HeraBEAT in Germany, Austria and Switzerland.

HeraMED shares are down 4.08 per cent and trading for 23.5 cents each at 2:20 pm.


Subscribe


HMD by the numbers
More From The Market Herald
G Medical Innovations (ASX:GMV) continues U.S. growth

" G Medical Innovations (ASX:GMV) continues U.S. growth

e-Health company G Medical Innovations (GMV) has updated the market on its rapid growth across the U.S. during the 2019 calendar year.
Bio-Gene Technology (ASX:BGT) is using Aussie eucalyptus to treat deadly diseases

" Bio-Gene Technology (ASX:BGT) is using Aussie eucalyptus to treat deadly diseases

Insecticide specialist Bio-Gene Technology (BGT) has discovered the secret to malaria control is in Aussie eucalypt trees.
Prescient Therapeutics (ASX:PTX) receives positive prognosis from  ovarian cancer trial

" Prescient Therapeutics (ASX:PTX) receives positive prognosis from ovarian cancer trial

Prescient Therapeutics (PTX) has received positive interim data from its phase 1b safety study of PTX-200.
Neuren Pharmaceuticals (ASX:NEU) updates market on 2019 milestones

" Paradigm Biopharmaceuticals (ASX:PAR) gets ready for a big 2020

Paradigm Biopharmaceuticals (PAR) has presented the market with an end of year update.